The prognostic impact of bone marrow micrometastases in women with breast cancer

Cancer Investigation

Volumn 27, Issue 6, 2009, Pages 598-603

  Braun, Stephan ^a   Auer, Doris ^a   Marth, Christian ^a  

^a INNSBRUCK MEDICAL UNIVERSITY   (Austria)

Author keywords

Breast cancer; Disseminated tumor cells; Predictive valve; Prognosis

Indexed keywords

ANASTROZOLE; FULVESTRANT;

ADJUVANT THERAPY; BONE MARROW METASTASIS; BREAST CANCER; CANCER GROWTH; CANCER MORTALITY; CANCER STAGING; CANCER SURVIVAL; CELL HETEROGENEITY; CLINICAL DECISION MAKING; CLINICAL TRIAL; DISSEMINATED TUMOR CELL; DRUG SAFETY; HUMAN; MICROMETASTASIS; PRIORITY JOURNAL; PROGNOSIS; REVIEW; TUMOR CELL; ANIMAL; BONE MARROW CANCER; BONE MARROW EXAMINATION; BREAST TUMOR; CANCER STEM CELL; DISEASE COURSE; FEMALE; METASTASIS; MORTALITY; PATHOLOGY; PREDICTION AND FORECASTING; TREATMENT OUTCOME; TUMOR EMBOLISM;

ANIMALS; BONE MARROW EXAMINATION; BONE MARROW NEOPLASMS; BREAST NEOPLASMS; DISEASE PROGRESSION; FEMALE; HUMANS; NEOPLASTIC CELLS, CIRCULATING; NEOPLASTIC STEM CELLS; PREDICTIVE VALUE OF TESTS; TREATMENT OUTCOME;

EID: 67649973938     PISSN: 07357907     EISSN: 15324192     Source Type: Journal    
DOI: 10.1080/07357900802574496     Document Type: Review

References (55)

1. Zeidman, I. The fate of circulating tumors cells. I. Passage of cells through capillaries. Cancer Res 1961, 21, 38-39.
2. 1-desoxyuridine. J Natl Cancer Inst 1970, 145, 773-782.
3. Mansi, J.L.; Berger, U.; Easton, D.; et al. Micrometastases in bone marrow in patients with primary breast cancer: evaluation as an early predictor of bone metastases. Br Med J 1987, 295, 1093-1096.
4. Untch, M.; Harbeck, N.; Eiermann, W. Micrometastases in bone marrow in patients with breast cancer. Br J Med 1988, 296, 290.
5. Porro, G.; Menard, S.; Tagliabue, E.; et al. Monoclonal antibody detection of carcinoma cells in bone marrow biopsy specimens from breast cancer patients. Cancer 1988, 61, 2407-2411.
6. Salvadori, B.; Squicciarini, P.; Rovini, D.; et al. Use of monoclonal antibody MBr1 to detect micrometastases in bone marrow specimens of breast cancer patients. Eur J Cancer 1990, 26, 865-867.
7. Kirk, S.J.; Cooper. G.G.; Hoper, M.; Watt, P.C.; Roy, A.D.; Olding- Smee, W. The prognostic signifi-cance of marrow micrometastases in women with early breast cancer. Eur J Surg Oncol 1990, 16, 481-485.
8. Cote, R.J.; Rosen, P.P.; Lesser, M.L.; Old, L.J.; Osborne, M.P. Prediction of early relapse in patients with operable breast cancer by detection of occult bone marrow micrometastases. J Clin Oncol 1991, 9, 1749-1756.
9. Mansi, J,L.; Berger, U.; Wilson, P.; Shearer, R.; Coombes, R.C. Detection of tumor cells in bone marrow of patients with prostatic carcinoma by immunocytochemical techniques. J Urol 1988, 139, 545-548. (Pubitemid 18082886)
10. Funke, I.; Fries, S.; Rolle, M.; et al. Comparative analyses of bone marrowmicrometastases in breast and gastric cancer. Int J Cancer 1996, 65, 755-761.
11. Diel, I.J.; Kaufmann, M.; Costa, S.D.; et al. Micrometastatic breast cancer cells in bone marrow at primary surgery: prognostic value in comparison with nodal status. J Natl Cancer Inst 1996, 88, 1652-1664.
12. Landys, K.; Persson, S.; Kovarik, J.; Hultborn, R.; Holmberg, E. Prognostic value of bone marrow biopsy in operable breast cancer patients at the time of initial diagnosis: results of a 20-year median follow-up. Breast Cancer Res Treat 1998, 49, 27-33. (Pubitemid 28279578)
13. Mansi, J.L.; Gogas, H.; Bliss, J.M.; Gazet, J.C.; Berger, U.; Coombes, R.C. Outcome of primarybreast-cancer patients with micrometastases: a long-term follow-up. Lancet 1999, 354(9174), 197-202. (Pubitemid 29329158)
14. Braun, S.; Pantel, K.; Müuller, P.; et al. Cytokeratin-positive cells in the bone marrow and survival of patients with stage I, II or III breast cancer. N Engl J Med 2000, 342(8), 525-533. (Pubitemid 30117892)
15. Gebauer, G.; Fehm, T.; Merkle, E.; Beck, E.P.; Lang, N.; Jager, W. Epithelial cells in bone marrow of breast cancer patients at time of primary surgery: clinical outcome during long-term follow-up. J Clin Oncol 2001, 19(16), 3669-3674. (Pubitemid 32786279)
16. Gerber, B.; Krause, A.; Muller, H.; et al. Simultaneous immunohistochemical detection of tumor cells in lymph nodes and bone marrow aspirates in breast cancer and its correlation with other prognostic factors. J Clin Oncol 2001, 19, 960-971.
17. Wiedswang, G.; Borgen, E.; Karesen, R.; et al. Detection of isolated tumor cells in bone marrow is an independent prognostic factor in breast cancer. J Clin Oncol 2003, 21(18), 3469-3478. (Pubitemid 46594079)
18. Pierga, J.-Y.; Bonneton, C.; Vincent-Salomon, A.; et al. Clinical significance of immunocytochemical detection of tumor cells using digital microscopy in peripheral blood and bone marrow of breast cancer patients. Clin Cancer Res 2004, 10(4), 1392-1400. (Pubitemid 38365234)
19. Heiss, M.M.; Allgayer, H.; Gruetzner, K.U.; et al. Individual development and uPA-receptor expression of disseminated tumour cells in bone marrow: a reference to early systemic disease in solid cancer. Nat Med 1995; 1(10), 1035-1039.
20. Braun, S.; Heumos, I.; Schlimok, G.; et al. ErbB2 over-expression on occult metastatic cells in bone marrow predicts poor clinical outcome of stage I-III breast cancer patients. Cancer Res 2001, 61, 1890-1895.
21. Solakoglu, O.; Maierhofer, C.; Lahr, G.; et al. Heterogeneous proliferative potential of occult metastatic cells in bone marrow of patients with solid epithelial tumors. Proc Natl Acad Sci 2002, 99(4), 2246-2251.
22. Klein, C.A.; Blankenstein, T.J.F.; Schmidt-Kittler, O.; et al. Genetic heterogeneity of single disseminated tumour cells in minimal residual cancer. The Lancet 2002, 360(9334), 683-689.
23. Schmidt-Kittler, O.; Ragg, T.; Daskalakis, A.; et al. From latent disseminated cells to overt metastasis: Genetic analysis of systemic breast cancer progression. Proc Natl Acad Sci 2003, 100, 7737-7742.
24. Offner, S.; Schmaus, W.; Witter, K.; et al. p53 mutations are not required for early dissemination of cancer cells. Proc Natl Acad Sci USA 1999, 96, 6942-6946.
25. Gray, J.W. Evidence emerges for early metastasis and parallel evolution of primary and metastatic tumors. Cancer Cell 2003, 4(1), 4-6.
26. Kuukasjarvi, T.; Karhu, R.; Tanner, M.; et al. Genetic heterogeneity and clonal evolution underlying development of asynchronous metastasis in human breast cancer. Cancer Res 1997, 57(8), 1597-1604.
27. Paget, S. Distribution of secondary growths in cancer of the breast. Lancet 1889, 1, 571.
28. Loh, E.; Couch, F.J.; Hendricksen, C.; et al. Development of donorderived prostate cancer in a recipient following orthotopic heart transplantation. J Am Med Assoc 1997, 277, 133-137.
29. Klein, C.A.; Schmidt-Kittler, O.; Schardt, J.A. Pantel, K.; Speicher, M.R.; Riethmü uller, G. Comparative genomic hybridization, loss of heterozygosity, and DNA sequence analysis of single cells. Proc Natl Acad Sci USA 1999, 96, 4494-4499.
30. Braun, S.; Vogl*, F.D.; Naume, B.; et al. A pooled analysis of bone marrow micrometastasis in breast cancer. NEJM 2005, 353(8), 793-802.
31. Goldhirsch, A.; Glick, J.H.; Gelber, R.D.; Coates, A.S.; Senn, H.J. Meeting highlights: international consensus panel on the treatment of primary breast cancer. J Clin Oncol 2001, 19, 3817-3827.
32. Goldhirsch, A.; Wood, W.C.; Gelber, R.D.; Coates, A.S.; Thurlimann, B.; Senn, H.-J. Meeting highlights: updated international expert consensus on the primary therapy of early breast cancer. J Clin Oncol 2003, 21(17), 3357-3365. (Pubitemid 46606270)
33. Hermanek, P. What's new in TNM? Pathol Res Pract 1994, 190, 97-102.
34. Hermanek, P.; Henson, D.E.; Hutter, R.V.; Sobin, L.H. TNM Supplement 1993. Berlin: Springer, 1993.
35. Hermanek, P.; Hutter, R.V.; Sobin, L.H.;Wittekind, C. Classification of isolated tumor cells and micrometastases. Cancer 1999, 86, 2668-2673.
36. Singletary, S.E.; Allred, C.,; Ashley, P.; et al. Revision of the American Joint Committee on cancer staging system for breast cancer. J Clin Oncol 2002, 20(17), 3628-3636. (Pubitemid 34983222)
37. Wong, G.Y.C.; Yu, Q.Q.; Osborne, M.P. Bone marrow micrometastasis is a significant predictor of long-term relapse-free survival for breast cancer by a non-proportional hazards model [abstr]. Breast Cancer Res Treat 2003, 82(suppl 1), S99.
38. Braun, S.; Cevatli, B.S.; Assemi, C.; et al. Comparative analysis of micrometastasis to the bone marrow and lymph nodes of nodenegative breast cancer patients receiving no adjuvant therapy. J Clin Oncol 2001, 19, 1468-1475.
39. Harbeck, N.; Untch, M.; Pache, L.; Eiermann, W. Tumour cell detection in the bone marrow of breast cancer patients at primary therapy: results of a 3-year median follow-up. Br J Cancer 1994; 69, 566-571. (Pubitemid 24076481)
40. Courtemanche, D.J.; Worth, A.J.; Coupland, R.W.; Rowell, J.L.; MacFarlane, J.K. Monoclonal antibody LICR-LON-M8 does not predict the outcome of operable breast cancer. Can J Surg 1991, 34, 21-26.
41. Singletary, S.E.; Larry, L.; Trucker, S.L.; Spitzer, G. Detection of micrometastatic tumor cells in bone marrow of breast carcinoma patients. J Surg Oncol 1991, 47, 32-36.
42. Mathieu, M.C.; Friedman, S.; Bosq, J.; et al. Immunohistochemical staining of bone marrow biopsies for detection of occult metastasis in breast cancer. Breast Cancer Res Treat 1990, 15(1), 21-26.
43. Weinschenker, P.; Soares, H.P.; Otavio Clark, O.; Del Giglio, A. Immunocytochemical detection of epithelial cells in the bone marrow of primary breast cancer patients: a metaanalysis. Breast Cancer Res Treat 2004, 87, 215-224. (Pubitemid 39505938)
44. Funke, I.; Schraut, W. Meta-analysis of studies on bone marrow micrometastases: an independent prognostic impact remains to be substantiated. J Clin Oncol 1998, 16, 557-566. (Pubitemid 28135599)
45. Hunink, M.G.; Wong, J.B. Meta-analysis of failure-time data with adjustment for covariates. Med Decis Mak 1994, 14, 59-70.
46. Clarke, M.J.; Stewart, L.A. Obtaining data from randomised controlled trials: how much do we need for reliable and informative meta-analyses? Brit Med J 1994, 309(6960), 1007-1010.
47. Thurm, H.; Ebel, S.; Kentenich, C.; et al. Rare expression of epithelial cell adhesion molecule on residual micrometastatic breast cancer cells after adjuvant chemotherapy. Clin Cancer Res 2003, 9(7), 2598-2604.
48. Braun, S.; Kentenich, C.R.M.; Janni, W.; et al. Lack of effect of adjuvant chemotherapy on the elimination of single dormant tumor cells in bone marrow of high-risk breast cancer patients. J Clin Oncol 2000, 18, 80-86.
49. Braun, S.; Hepp, F.; Kentenich. C.R.M.; et al. Monoclonal antibody therapy with edrecolomab in breast cancer patients: monitoring of elimination of disseminated cytokeratin-positive tumor cells in bone marrow. Clin Cancer Res 1999, 5, 3999-4004.
50. Pantel, K.; Enzmann, T.; Köullermann, J.; Caprano, J.; Riethmüuller, G.; Köullermann, M.W. Immunocytochemical monitoring of micrometastatic disease: reduction of prostate cancer cells in bone marrow by androgen deprivation. Int J Cancer 1997, 71, 521-525.
51. Schlimok, G.; Pantel, K.; Loibner, H.; Fackler-Schwalbe, I.; Riethmüuller, G. Reduction of metastatic carcinoma cells in bone marrow by intravenously administered monoclonal antibody: towards a novel surrogate test to monitor adjuvant therapies of solid tumours. Eur J Cancer 1995, 31A, 1799-1803.
52. Janni, W.; Rack, B.; Schindlbeck, C.; et al. The persistence of isolated tumor cells in bone marrow from patients with breast carcinoma predicts an increased risk for recurrence. Cancer 2005, 103, 884-891. (Pubitemid 40270064)
53. Wiedswang, G.; Borgen, E.; Køaresen, R.; et al. Isolated tumor cells in bone marrow 3 years after diagnosis in disease free breast cancer patients predict unfavorable clinical outcome. Clin Cancer Res 2004, 10(16), 5342-5348. (Pubitemid 39100469)
54. Cristofanilli, M.; Budd, G.T.; Ellis,M.J.; et al. Circulating tumor cells, disease progression and survival in metastatic breast cancer. N Engl J Med 2004, 351(8), 781-791. (Pubitemid 39095313)
55. (http://www.abcsg.at/abcsg/html studien/mamma offen.html)